Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial
- Inovio tumbled nearly 30% on Friday after the company said the government will stop funding a late-stage study of its COVID-19
- Inovio said the decision stems from the 'rapid deployment of vaccines' and isn't a reflection on its INO-4800 candidate.
- The biotech firm said it will work with its global partners on the Phase 3 vaccine trial.
Inovio Pharmaceuticals shares were chopped down by nearly a third on Friday after the US government said it will discontinue funding for a late-phase trial of the company's COVID-19 vaccine candidate.The biotech company said it was informed that it will lose federal financial support for the phase three segment of its Innovate trial for INO-4800. The DNA vaccine candidate is aimed at preventing infection from SARS-CoV-2, the coronavirus behind the COVID-19 disease.
The government will complete the funding for the phase 2 trial of INO-4800, the company said, which added that the phase 3 funding decision does not impact its other work with the US government.The US has been ramping up the nationwide rollout of COVID-19 vaccines made by Pfizer and Moderna. This week, President Joe Biden said his administration reached its goal of completing 200 million vaccine shots during his first 100 days in office.
Inovio will continue working with other global partners on the late-stage study of INO-4800, including Advaccine Biopharmaceuticals, its partner in China.Inovio also said it will keep evaluating its pan-COVID variant vaccine, INO-4802, and assessing boosting capabilities for INO-4800. "Inovio remains well-positioned to support both pandemic and endemic vaccine needs with INO-4800 and INO-4802," it said.
- Best office chairs for working from home
- Delhi unlock: Restaurants to reopen with 50% capacity; malls, markets to open daily, says Arvind Kejriwal
- Budget constraint cannot justify violation of citizens' right to clean environment: NGT
- Weekly crypto roundup: WazirX under scrutiny, El Salvador makes Bitcoin legal tender and more
- BSE and NSE suspend trading in shares of Dewan Housing Finance Corporation Ltd (DHFL) from Monday